2. Academic Validation
  3. Structure-activity relationships among DNA ligase inhibitors: Characterization of a selective uncompetitive DNA ligase I inhibitor

Structure-activity relationships among DNA ligase inhibitors: Characterization of a selective uncompetitive DNA ligase I inhibitor

  • DNA Repair (Amst). 2017 Dec;60:29-39. doi: 10.1016/j.dnarep.2017.10.002.
Timothy R L Howes 1,  Annahita Sallmyr 1,  Rhys Brooks 1,  George E Greco 2,  Darin E Jones 3,  Yoshihiro Matsumoto 1,  Alan E Tomkinson 4
Affiliations

Affiliations

  • 1 Departments of Internal Medicine, Molecular Genetics and Microbiology and the University of New Mexico Comprehensive Cancer Center, University of New Mexico, Albuquerque, NM 87131, United States.
  • 2 Department of Chemistry, Goucher College, Baltimore, MD 21204, United States.
  • 3 Department of Chemistry, University of Arkansas at Little Rock, Little Rock, AR 72204, United States.
  • 4 Departments of Internal Medicine, Molecular Genetics and Microbiology and the University of New Mexico Comprehensive Cancer Center, University of New Mexico, Albuquerque, NM 87131, United States. Electronic address: atomkinson@salud.unm.edu.
PMID: 29078112 DOI: 10.1016/j.dnarep.2017.10.002
Abstract

In human cells, there are three genes that encode DNA Ligase polypeptides with distinct but overlapping functions. Previously small molecule inhibitors of human DNA ligases were identified using a structure-based approach. Three of these inhibitors, L82, a DNA Ligase I (LigI)-selective inhibitor, and L67, an inhibitor of LigI and DNA ligases III (LigIII), and L189, an inhibitor of all three human DNA ligases, have related structures that are composed of two 6-member aromatic rings separated by different linkers. Here we have performed a structure-activity analysis to identify determinants of activity and selectivity. The majority of the LigI-selective inhibitors had a pyridazine ring whereas the LigI/III- and LigIII-selective inhibitors did not. In addition, the aromatic rings in LigI-selective inhibitors had either arylhydrazone or acylhydrazone, but not vinyl linkers. Among the LigI-selective inhibitors, L82-G17 exhibited increased activity against and selectivity for LigI compared with L82. Notably. L82-G17 is an uncompetitive inhibitor of the third step of the ligation reaction, phosphodiester bond formation. Cells expressing LigI were more sensitive to L82-G17 than isogenic LIG1 null cells. Furthermore, cells lacking nuclear LigIIIα, which can substitute for LigI in DNA replication, were also more sensitive to L82-G17 than isogenic parental cells. Together, our results demonstrate that L82-G17 is a LigI-selective inhibitor with utility as a probe of the catalytic activity and cellular functions of LigI and provide a framework for the future design of DNA Ligase inhibitors.

Keywords

DNA replication; Enzyme-substrate complex; Michaelis-Menten kinetics; Nucleotidyl transfer; Phosphodiester bond formation.

Figures
Products